MON-112 Home Haemodialysis (HHD) with low dialysate volume (LDV) – The green benefit

Objectives To determine the effect of changing dialysate volume on urea and glucoseequilibration curves and to determine, if dialysate volume is prescribed on the basis of body surface area, whether equilibration curves will be consistent in patients of different sizes and ages. Design A prospective study wherein children with acute or chronic renal failure had peritoneal equilibration studies done with dwell volumes of 30 mL/kg, 40 mL/kg, and 1200 mL/m2. Patient Population Twenty-two children: 7 under 3 years of age; 8 between 3 and 10 years of age; 7 older than 10 years of age. Statistics Student's t-test. Results Urea and glucose equilibrated rapidly at dwell volumes of 30 mL/kg, slower at dwell volumes of 40 mL/kg, and slowest at dwell volumes of 1200 mL/m2. Equilibration curves were similar in children of different ages when dialysate volumes of 1200 mL/m2 were infused. Conclusion Dialysate volumes of 1200 mL/m2 should be used when equilibration studies are being done to compare individuals of different ages and sizes.

Download Full-text

Clinical study on low-molecular weight heparin infusion as anticoagulation for nocturnal home haemodialysis

Nephrology ◽

10.1111/nep.12995 ◽

2018 ◽

Vol 23 (4) ◽

pp. 317-322 ◽

Cited By ~ 3

Author(s):

Steve Siu-Man Wong ◽

Wai-Yan Lau ◽

Man-Luen Ng ◽

Shuk-Yin Chan ◽

So-Fan Chan ◽

...

Keyword(s):

Molecular Weight ◽

Clinical Study ◽

Low Molecular Weight Heparin ◽

Low Molecular Weight ◽

Heparin Infusion ◽

Home Haemodialysis

Download Full-text

Patients’ and carers’ experiences of interacting with home haemodialysis technology: implications for quality and safety

BMC Nephrology ◽

10.1186/1471-2369-15-195 ◽

2014 ◽

Vol 15 (1) ◽

Cited By ~ 15

Author(s):

Atish Rajkomar ◽

Ken Farrington ◽

Astrid Mayer ◽

Diane Walker ◽

Ann Blandford

Keyword(s):

Quality And Safety ◽

Home Haemodialysis

Download Full-text

Nocturnal home haemodialysis: The 17 years experience of a single Australian dialysis service

Nephrology ◽

10.1111/nep.13524 ◽

2019 ◽

Vol 24 (10) ◽

pp. 1050-1055

Author(s):

Shi Z Choo ◽

Emily J See ◽

Rosemary E Simmonds ◽

Christine A Somerville ◽

John W M Agar

Keyword(s):

Home Haemodialysis

Download Full-text

Changes in serum prolactin, sex hormones and thyroid function with alternate nightly nocturnal home haemodialysis

Nephrology ◽

10.1111/j.1440-1797.2011.01520.x ◽

2011 ◽

Vol 17 (1) ◽

pp. 42-47 ◽

Cited By ~ 29

Author(s):

CAROLYN VAN EPS ◽

CARMEL HAWLEY ◽

JANINE JEFFRIES ◽

DAVID W JOHNSON ◽

SCOTT CAMPBELL ◽

...

Keyword(s):

Sex Hormones ◽

Thyroid Function ◽

Serum Prolactin ◽

Home Haemodialysis

Download Full-text

Design, Implementation and Preliminary Evaluation of a Telemedicine System for Home Haemodialysis

Journal of Telemedicine and Telecare ◽

10.1177/1357633x0200800306 ◽

2002 ◽

Vol 8 (3) ◽

pp. 157-164 ◽

Cited By ~ 6

Author(s):

Marios Skiadas ◽

Basil Agroyiannis ◽

Ewart Carson ◽

Derek Cramp ◽

Costas Fourtounas ◽

...

Keyword(s):

Formative Evaluation ◽

Systems Approach ◽

Preliminary Evaluation ◽

Telemedicine System ◽

Home Haemodialysis ◽

Feedback Model ◽

Software Specifications ◽

Detailed Specification ◽

Criterion Matrix ◽

Stakeholder Evaluation

A telemedicine system for home haemodialysis was designed using a systems approach and a feedback model to produce the hardware and software specifications. Preliminary clinical trials at four European locations involved 29 patients and 305 sessions of haemodialysis. The evaluation included an evaluability assessment and formative evaluation. Central to the methodology was the detailed specification of a stakeholder/evaluation criterion matrix. Preliminary results indicated that the telemedicine system was capable of satisfying the requirements of formative evaluation as a precursor to evaluating its overall worth.

Download Full-text

Home Haemodialysis in Children

Pediatric Dialysis ◽

10.1007/978-3-030-66861-7_23 ◽

2021 ◽

pp. 389-400

Author(s):

Daljit K. Hothi ◽

Claus Peter Schmitt

Keyword(s):

Home Haemodialysis

Download Full-text

Peritoneal Solute Clearances after four Years of Continuous Ambulatory Peritoneal Dialysis (CAPD)

Peritoneal Dialysis International ◽

10.1177/089686088900900116 ◽

1989 ◽

Vol 9 (1) ◽

pp. 75-78 ◽

Cited By ~ 19

Author(s):

Min Sun Park ◽

Jean Lee ◽

Moon Sung Lee ◽

Seung Ho Baick ◽

Seung Duk Hwang ◽

...

Keyword(s):

Peritoneal Dialysis ◽

Continuous Ambulatory Peritoneal Dialysis ◽

Glucose Absorption ◽

Peritoneal Membrane ◽

Vasoactive Agents ◽

Membrane Function ◽

Dialysis Solution ◽

Before And After ◽

Dialysate Volume

In order to evaluate peritoneal membrane function and responsiveness of peritoneal microcirculation to vasoactive agents in long-term continuous ambulatory peritoneal dialysis (CAPD) patients, we studied peritoneal clearances of urea (Curea) and creatinine (Ccr), protein concentrations in drained dialysate (D PC), peritoneal glucose absorption (% GA), and drained dialysate volume ( VD) before and after nitroprusside (NP) addition to dialysis solution in 17 long-term CAPD patients (mean duration of CAPD: 52 months) and the results were compared to those of 18 patients who were just trained for CAPD (mean duration: 0.6 month). There were no differences in the control (without NP) Curea, Ccr, D PC, %GA, and VD between the new and long-term CAPD patients. Curea, Ccr, and D PC increased significantly with NP in both new and long-term patients. Curea and Ccr with NP were not different between the new and long-term patients but D PC with NP was significantly lower in the long-term CAPD patients. The results of this study suggest that peritoneal solute clearances and the responsiveness of peritoneal microcirculation to NP remain unchanged after four years of CAPD, despite recurrent episodes of peritonitis.

Download Full-text

Home haemodialysis

Journal of Kidney Care ◽

10.12968/jokc.2019.4.5.238 ◽

2019 ◽

Vol 4 (5) ◽

pp. 238-238

Author(s):

David Mantle

Keyword(s):

Home Haemodialysis

Download Full-text

Determining Peritoneal Dialysis Prescriptions by Employing a Patient -Specific Protocol

Peritoneal Dialysis International ◽

10.1177/089686089301300305 ◽

1993 ◽

Vol 13 (3) ◽

pp. 189-193 ◽

Cited By ~ 5

Author(s):

Paul M. Zabetakis ◽

Randi Krapf ◽

Maria v. DeVita ◽

Gilbert W. Gleim ◽

Michael F. Michelis

Keyword(s):

New York ◽

Peritoneal Dialysis ◽

Creatinine Clearance ◽

Treatment Protocol ◽

Specific Treatment ◽

Simple Calculation ◽

Patient Specific ◽

Specific Protocol ◽

Continuous Cycling ◽

Dialysate Volume

Objective To develop a formula that would permit a rapid and simple calculation of required dialysate volume needed to provide a predetermined daily creatinine clearance. Design Prospective study of peritoneal dialysis patients followed for 6 months. Setting A primary care teaching hospital in New York. Patients Twenty-six patients beginning peritoneal dialysis entered and completed the study. Intervention By employing each patient's measured peritoneal equilibration test (PET) and a standard clearance formula, a patient-specific treatment protocol (PSP) was calculated. The PET 2-hour DIP croat was used for continuous cycling peritoneal dialysis (CCPD) and the 4hour DIP patients on continuous ambulatory peritcornoeal dialysis (CAPD) to determine a PSP that would provide a minimum of 6 L of creatinine clearance daily. Main Outcome Measures Patients were followed for 6 months to assess the ability of this approach of maintaining acceptable levels of blood urea nitrogen, creatinine, albumin, and hematocrit over the 6–month period of observation. Results Our study of 26 patients revealed that only 6 patients (23%) could be treated with the standard prescription of 8 L/day on CAPD. The remaining 77% of our patients required 9–13 L/day for CAPD and 12–21 L/day for CCPD. All patients were free of uremic symptoms and demonstrated acceptable biochemical parameters over a 3–6 month period of observation. Conclusions A patient-specific protocol utilizing individually derived PET data provides an acceptable and easy to calculate initial treatment prescription for each patient that avoids the necessity for trial and error that has heretofore been employed.

Download Full-text